MedPath

Alendronate Sodium

ALENDRONATE SODIUM TABLETS, USP

Approved
Approval ID

62af73fb-c9b7-4034-9794-dbb50420e62b

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 28, 2010

Manufacturers
FDA

Dispensing Solutions Inc.

DUNS: 066070785

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

alendronate sodium

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code68258-3014
Application NumberANDA076984
Product Classification
M
Marketing Category
C73584
G
Generic Name
alendronate sodium
Product Specifications
Route of AdministrationORAL
Effective DateJanuary 28, 2010
FDA Product Classification

INGREDIENTS (5)

ALENDRONATE SODIUMActive
Quantity: 70 mg in 1 1
Code: 2UY4M2U3RA
Classification: ACTIM
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.